Metabolic syndrome components determine the presence of subclinical atherosclerosis in obese and overweight.

Metabolic syndrome (MS) is frequently associated with an increased body mass index (BMI), and related to an adverse cardiovascular prognosis. The purpose of this study is to evaluate the prevalence and association between MS, obesity and subclinical atherosclerosis (SA). This cross-sectional study included healthy adults, allocated to normal weight (NW) when BMI <25 kg/m, overweight (OW) BMI ≥25 and <30 kg/m, or obese (OB) BMI ≥30 kg/m groups.